Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-relat… (NCT06676839) | Clinical Trial Compass
RecruitingNot Applicable
Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)
France1,000 participantsStarted 2024-10-14
Plain-language summary
The World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, Comprehensive Assessment, Personalized Prevention and Care Plan, Follow-up). The screening tool assesses a person's intrinsic capacity in six key functional domains (mobility, cognition, nutrition, vision, hearing, psychological well-being). This screening can be conducted by a professional or through self-assessment using the digital application (ICOPE Monitor). If a deficit is detected, an alert is issued, and if confirmed by a healthcare professional trained in ICOPE, a comprehensive assessment of the impaired function and a personalized prevention and care plan is proposed by the physician. A trained nurse assists the person in implementing this plan in collaboration with the primary care physician and local professionals. When multiple functions are impaired, it is recommended to conduct a thorough evaluation of all six functions to implement an integrated approach.
The clinical effectiveness of the program in preventing functional decline has not yet been established in a sufficiently long trial.
The investigators propose to evaluate the effect and cost of the ICOPE program in France through a controlled trial. Our hypothesis is that, in the current primary care context, the comprehensive implementation of the program (combining regular screening, comprehensive assessment, prevention and care plan, and follow-up) is necessary to more effectively prevent age-related functional decline compared to the usual care provided by the primary care physician.
Who can participate
Age range65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Participants aged 65 years and older.
✓. Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
✓. Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.
✓. Participants affiliated with a social protection system.
Exclusion criteria
✕. Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
✕. Participants living in a dependent elderly care facility.
✕. Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).
✕. Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.